Quadrature Capital LTD Bio Techne Corp Transaction History

Quadrature Capital LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $2.57 Million - $3.11 Million	35,871 New	35,871 $2.66 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $5.53 Million - $7.67 Million	-19,571 Reduced 75.63%	6,307 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $8.35 Million - $11.6 Million	25,878 New	25,878 $8.98 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $247,695 - $341,453	-700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $319,305 - $367,541	700 New	700 $362,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $507,167 - $662,532	-1,612 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $277,762 - $362,103	-1,125 Reduced 41.1%	1,612 $512,000
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $217,590 - $265,133	937 Added 52.06%	2,737 $678,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $222,516 - $335,472	-1,200 Reduced 40.0%	1,800 $475,000
Q2 2018 Aug 10, 2018	BUY	$144.9 - $165.58 $434,700 - $496,740	3,000 New	3,000 $0

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.